Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
More organizations
Companies
JUNTEN BIO
Team
Team
Save
JUNTEN BIO
Developing new technologies in the field of regenerative medicine.
Learn more
Launch date
Jun 2018
Employees
2-10 people
Market cap
-
Enterprise valuation
$18—28m
(Dealroom.co estimates Jan 2021.)
Tokyo Japan (HQ)
http://juntenbio.co.jp
https://www.linkedin.com/company/junten-bio/
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (5)
Authorizing premium user...